These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34974319)

  • 1. Menthol-assisted homogenous liquid-liquid microextraction for HPLC/UV determination of favipiravir as an antiviral for COVID-19 in human plasma.
    Abdallah IA; Hammad SF; Bedair A; Mansour FR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Jan; 1189():123087. PubMed ID: 34974319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of favipiravir in human plasma using homogeneous liquid-liquid microextraction followed by HPLC/UV.
    Abdallah IA; Hammad SF; Bedair A; Elshafeey AH; Mansour FR
    Bioanalysis; 2022 Feb; 14(4):205-216. PubMed ID: 35001648
    [No Abstract]   [Full Text] [Related]  

  • 3. A gadolinium-based magnetic ionic liquid for supramolecular dispersive liquid-liquid microextraction followed by HPLC/UV for the determination of favipiravir in human plasma.
    Abdallah IA; Hammad SF; Bedair A; Abdelaziz MA; Danielson ND; Elshafeey AH; Mansour FR
    Biomed Chromatogr; 2022 Jun; 36(6):e5365. PubMed ID: 35274347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a sensitive, fast and simple LC-MS / MS method for the quantitation of favipiravir in human serum.
    Eryavuz Onmaz D; Abusoglu S; Onmaz M; Yerlikaya FH; Unlu A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jun; 1176():122768. PubMed ID: 34052564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Validation of a Method for Quantification of Favipiravir as COVID-19 Management in Spiked Human Plasma.
    Hailat M; Al-Ani I; Hamad M; Zakareia Z; Abu Dayyih W
    Molecules; 2021 Jun; 26(13):. PubMed ID: 34206357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of Analytical Procedure for In-hospital Rapid Quantification of Serum Level of Favipiravir in the Pharmacological Treatment of COVID-19.
    Moriiwa Y; Morikawa G; Okazawa K; Yanagida A
    Anal Sci; 2021 Sep; 37(9):1301-1304. PubMed ID: 33612558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Outcomes and Plasma Concentrations of Baloxavir Marboxil and Favipiravir in COVID-19 Patients: An Exploratory Randomized, Controlled Trial.
    Lou Y; Liu L; Yao H; Hu X; Su J; Xu K; Luo R; Yang X; He L; Lu X; Zhao Q; Liang T; Qiu Y
    Eur J Pharm Sci; 2021 Feb; 157():105631. PubMed ID: 33115675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental design approach for development of spectrofluorimetric method for determination of favipiravir; a potential therapeutic agent against COVID-19 virus: Application to spiked human plasma.
    Megahed SM; Habib AA; Hammad SF; Kamal AH
    Spectrochim Acta A Mol Biomol Spectrosc; 2021 Mar; 249():119241. PubMed ID: 33333412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vortex-Assisted Dispersive Liquid-Liquid Microextraction Coupled with Deproteinization for Determination of Nateglinide in Human Plasma Using HPLC/UV.
    Hammad MA; Kamal AH; Kannouma RE; Mansour FR
    J Chromatogr Sci; 2021 Feb; 59(3):297-304. PubMed ID: 33275653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Non-Instrumental Green Analytical Method Based on Surfactant-Assisted Dispersive Liquid-Liquid Microextraction-Thin-Layer Chromatography-Smartphone-Based Digital Image Colorimetry(SA-DLLME-TLC-SDIC) for Determining Favipiravir in Biological Samples.
    Jain B; Jain R; Jaiswal PK; Zughaibi T; Sharma T; Kabir A; Singh R; Sharma S
    Molecules; 2023 Jan; 28(2):. PubMed ID: 36677588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of favipiravir in the treatment of COVID-19.
    Joshi S; Parkar J; Ansari A; Vora A; Talwar D; Tiwaskar M; Patil S; Barkate H
    Int J Infect Dis; 2021 Jan; 102():501-508. PubMed ID: 33130203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two Green Micellar HPLC and Mathematically Assisted UV Spectroscopic Methods for the Simultaneous Determination of Molnupiravir and Favipiravir as a Novel Combined COVID-19 Antiviral Regimen.
    Sharaf YA; El Deeb S; Ibrahim AE; Al-Harrasi A; Sayed RA
    Molecules; 2022 Apr; 27(7):. PubMed ID: 35408729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel LC-MS/MS method for determination of the potential antiviral candidate favipiravir for the emergency treatment of SARS-CoV-2 virus in human plasma: Application to a bioequivalence study in Egyptian human volunteers.
    Morsy MI; Nouman EG; Abdallah YM; Zainelabdeen MA; Darwish MM; Hassan AY; Gouda AS; Rezk MR; Abdel-Megied AM; Marzouk HM
    J Pharm Biomed Anal; 2021 May; 199():114057. PubMed ID: 33831737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of teicoplanin in human plasma by reverse micelle mediated dispersive liquid-liquid microextraction with high performance liquid chromatography.
    Zhang YF; Zheng XJ; Tian J; Hu S; Bai XH; Chen X
    J Chromatogr A; 2021 Apr; 1643():462058. PubMed ID: 33756356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Favipiravir-induced fever in coronavirus disease 2019: A report of two cases.
    Takoi H; Togashi Y; Fujimori D; Kaizuka H; Otsuki S; Wada T; Takeuchi Y; Abe S
    Int J Infect Dis; 2020 Dec; 101():188-190. PubMed ID: 32992014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Favipiravir in the treatment of patients with SARS-CoV-2 RNA recurrent positive after discharge: A multicenter, open-label, randomized trial.
    Zhao H; Zhang C; Zhu Q; Chen X; Chen G; Sun W; Xiao Z; Du W; Yao J; Li G; Ji Y; Li N; Jiang Y; Wang Y; Zeng Q; Li W; Gong B; Chang X; Zhu F; Jiang X; Li J; Wu Z; Liu Y; Peng P; Wang G
    Int Immunopharmacol; 2021 Aug; 97():107702. PubMed ID: 33930706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly sensitive high-performance thin-layer chromatography method for the simultaneous determination of molnupiravir, favipiravir, and ritonavir in pure forms and pharmaceutical formulations.
    Saraya RE; Deeb SE; Salman BI; Ibrahim AE
    J Sep Sci; 2022 Jul; 45(14):2582-2590. PubMed ID: 35583051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ion-pair vortex assisted liquid-liquid microextraction with back extraction coupled with high performance liquid chromatography-UV for the determination of metformin in plasma.
    Alshishani A; Makahleh A; Yap HF; Gubartallah EA; Salhimi SM; Saad B
    Talanta; 2016 Dec; 161():398-404. PubMed ID: 27769423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Prospective, Randomized, Open-Label Trial of Early versus Late Favipiravir Therapy in Hospitalized Patients with COVID-19.
    Doi Y; Hibino M; Hase R; Yamamoto M; Kasamatsu Y; Hirose M; Mutoh Y; Homma Y; Terada M; Ogawa T; Kashizaki F; Yokoyama T; Koba H; Kasahara H; Yokota K; Kato H; Yoshida J; Kita T; Kato Y; Kamio T; Kodama N; Uchida Y; Ikeda N; Shinoda M; Nakagawa A; Nakatsumi H; Horiguchi T; Iwata M; Matsuyama A; Banno S; Koseki T; Teramachi M; Miyata M; Tajima S; Maeki T; Nakayama E; Taniguchi S; Lim CK; Saijo M; Imai T; Yoshida H; Kabata D; Shintani A; Yuzawa Y; Kondo M
    Antimicrob Agents Chemother; 2020 Nov; 64(12):. PubMed ID: 32958718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescence of ocular surface in a Covid -19 patient after Favipiravir treatment: a case report.
    Doran MA; Aytogan H; Ayıntap E
    Virol J; 2021 Jul; 18(1):146. PubMed ID: 34256791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.